Brief: Duke-Nus And Genscript Announce Notice Of Allowance For U.S. Patent Application For Sars-Cov-2 Surrogate Virus Neutralization Test
June 21 (Reuters) - Genscript Biotech Corp 1548.HK :
* DUKE-NUS AND GENSCRIPT ANNOUNCE NOTICE OF ALLOWANCE FOR
U.S.
PATENT APPLICATION FOR SARS-COV-2 SURROGATE VIRUS NEUTRALIZATION
TEST
Source text for Eikon: ID:nPn5Q3Qpga
Further company coverage: 1548.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Genscript Biotech
See all newsBrief: Genscript Launches Life Sciences Startup Pitchfest With Nvidia For Biotech Innovation
GenScript Biotech extends gain to hit near 5-year peak on Eli Lilly deal
GenScript Biotech hits near 5-year high on Eli Lilly collaboration
Brief: ProBio & Kun Tuo Announce Strategic Collaboration To Deliver Integrated CDMO-CRO Solutions
HK-listed GenScript Biotech drops on discounted share sale